Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth
Abstract Background Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear. Methods The expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The pro...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-12-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-022-10368-y |
| _version_ | 1811190441951887360 |
|---|---|
| author | Yan Yan Yonghua Chen Jiahao Pan Wei Xing Qiang Li Yan Wang Liba Gei Yunfei Yuan Jingdun Xie Weian Zeng Dongtai Chen |
| author_facet | Yan Yan Yonghua Chen Jiahao Pan Wei Xing Qiang Li Yan Wang Liba Gei Yunfei Yuan Jingdun Xie Weian Zeng Dongtai Chen |
| author_sort | Yan Yan |
| collection | DOAJ |
| description | Abstract Background Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear. Methods The expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The prognostic value of DRD3 in patients was investigated by analyzing selected databases, including cBioPortal and Kaplan–Meier plotter. Cell growth was tested by CCK8 assay, and Transwell assays were performed to assess cancer cell migration and invasion. The cAMP/ERK/CREB signaling pathway was evaluated by Western blot analysis and ELISA. An HCC xenograft model was established for in vivo experiments. Results DRD3 mRNA expression was significantly higher in nontumor tissues than in tumor tissues. Lower protein expression of DRD3 was related to poor recurrence-free survival (RFS) and overall survival (OS). Kaplan–Meier plotter analysis showed that higher expression of DRD3 mRNA was associated with better OS, RFS, disease-specific survival (DSS), and progression-free survival (PFS). cBioPortal analysis revealed that the alteration group, which harbored genetic mutations in DRD3, exhibited poor OS, RFS, DSS and PFS. According to CCK8 and Transwell assays, stable DRD3 overexpression cell line (ex-DRD3-SK-HEP-1) showed weaker proliferation, migration and invasion behaviors. PD128907, a DRD3 agonist, suppressed proliferation, migration and invasion in HCC cell lines, while U99194, a DRD3 antagonist, enhanced proliferation, migration and invasion in HCC cell lines. Western blot analysis and ELISA revealed that stable DRD3 knock-down cell line (sh-DRD3-PLC/PRF/5) and U99194 both increased the protein levels of cAMP, p-ERK and p-CREB; on the other hand, ex-DRD3-SK-HEP-1 and PD128907 decreased the protein levels of cAMP, p-ERK and p-CREB. SCH772984, an ERK antagonist, abolished the effect of U99194 on the malignant biological behaviors of HCC cells. In vivo, PD128907 suppressed tumor growth, and U99194 enhanced tumor growth. Conclusion Our results suggest that down-regulation of DRD3 is strongly involved in the progression of HCC, and DRD3 might be consider as an independent prognostic factor for HCC. Furthermore, DRD3 agonists may be a promising strategy for HCC therapy. |
| first_indexed | 2024-04-11T14:51:17Z |
| format | Article |
| id | doaj.art-ffc3876f7a6b453fbf9ed0b4b953621d |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-04-11T14:51:17Z |
| publishDate | 2022-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-ffc3876f7a6b453fbf9ed0b4b953621d2022-12-22T04:17:28ZengBMCBMC Cancer1471-24072022-12-0122111510.1186/s12885-022-10368-yDopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growthYan Yan0Yonghua Chen1Jiahao Pan2Wei Xing3Qiang Li4Yan Wang5Liba Gei6Yunfei Yuan7Jingdun Xie8Weian Zeng9Dongtai Chen10Department of Anesthesiology, Huizhou Municipal Central HospitalDepartment of Anesthesiology, Peking University Shenzhen HospitalDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterAbstract Background Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear. Methods The expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The prognostic value of DRD3 in patients was investigated by analyzing selected databases, including cBioPortal and Kaplan–Meier plotter. Cell growth was tested by CCK8 assay, and Transwell assays were performed to assess cancer cell migration and invasion. The cAMP/ERK/CREB signaling pathway was evaluated by Western blot analysis and ELISA. An HCC xenograft model was established for in vivo experiments. Results DRD3 mRNA expression was significantly higher in nontumor tissues than in tumor tissues. Lower protein expression of DRD3 was related to poor recurrence-free survival (RFS) and overall survival (OS). Kaplan–Meier plotter analysis showed that higher expression of DRD3 mRNA was associated with better OS, RFS, disease-specific survival (DSS), and progression-free survival (PFS). cBioPortal analysis revealed that the alteration group, which harbored genetic mutations in DRD3, exhibited poor OS, RFS, DSS and PFS. According to CCK8 and Transwell assays, stable DRD3 overexpression cell line (ex-DRD3-SK-HEP-1) showed weaker proliferation, migration and invasion behaviors. PD128907, a DRD3 agonist, suppressed proliferation, migration and invasion in HCC cell lines, while U99194, a DRD3 antagonist, enhanced proliferation, migration and invasion in HCC cell lines. Western blot analysis and ELISA revealed that stable DRD3 knock-down cell line (sh-DRD3-PLC/PRF/5) and U99194 both increased the protein levels of cAMP, p-ERK and p-CREB; on the other hand, ex-DRD3-SK-HEP-1 and PD128907 decreased the protein levels of cAMP, p-ERK and p-CREB. SCH772984, an ERK antagonist, abolished the effect of U99194 on the malignant biological behaviors of HCC cells. In vivo, PD128907 suppressed tumor growth, and U99194 enhanced tumor growth. Conclusion Our results suggest that down-regulation of DRD3 is strongly involved in the progression of HCC, and DRD3 might be consider as an independent prognostic factor for HCC. Furthermore, DRD3 agonists may be a promising strategy for HCC therapy.https://doi.org/10.1186/s12885-022-10368-yDopamine receptor D3Hepatocellular carcinomaPrognosisTarget therapyERK pathway |
| spellingShingle | Yan Yan Yonghua Chen Jiahao Pan Wei Xing Qiang Li Yan Wang Liba Gei Yunfei Yuan Jingdun Xie Weian Zeng Dongtai Chen Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth BMC Cancer Dopamine receptor D3 Hepatocellular carcinoma Prognosis Target therapy ERK pathway |
| title | Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth |
| title_full | Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth |
| title_fullStr | Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth |
| title_full_unstemmed | Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth |
| title_short | Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth |
| title_sort | dopamine receptor d3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth |
| topic | Dopamine receptor D3 Hepatocellular carcinoma Prognosis Target therapy ERK pathway |
| url | https://doi.org/10.1186/s12885-022-10368-y |
| work_keys_str_mv | AT yanyan dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT yonghuachen dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT jiahaopan dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT weixing dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT qiangli dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT yanwang dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT libagei dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT yunfeiyuan dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT jingdunxie dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT weianzeng dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth AT dongtaichen dopaminereceptord3isrelatedtoprognosisinhumanhepatocellularcarcinomaandinhibitstumorgrowth |